ASP Isotopes Files 8-K Report
Ticker: ASPI · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1921865
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
ASP Isotopes filed an 8-K on Nov 17, 2025, covering Reg FD and financials.
AI Summary
ASP Isotopes Inc. filed an 8-K report on November 17, 2025, disclosing information related to Regulation FD and financial statements. The filing indicates the company's principal executive offices are located at 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.
Why It Matters
This 8-K filing serves as an official notification to the SEC and the public about significant corporate events or disclosures for ASP Isotopes Inc.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain any immediate negative or positive financial news.
Key Players & Entities
- ASP Isotopes Inc. (company) — Registrant
- November 17, 2025 (date) — Date of earliest event reported
- 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004 (location) — Address of principal executive offices
- 202-756-2245 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by ASP Isotopes Inc.?
The 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting information related to Regulation FD Disclosure and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on November 17, 2025.
What is the official address of ASP Isotopes Inc.'s principal executive offices?
The address of ASP Isotopes Inc.'s principal executive offices is 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.
What is the telephone number for ASP Isotopes Inc.?
The registrant's telephone number, including area code, is (202) 756-2245.
In which state is ASP Isotopes Inc. incorporated?
ASP Isotopes Inc. is incorporated in Delaware.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-11-17 17:23:10
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 ASPI The Nasdaq Stock Market LLC
Filing Documents
- aspi_8k.htm (8-K) — 27KB
- aspi_ex991.htm (EX-99.1) — 8KB
- aspi_ex991img1.jpg (GRAPHIC) — 3KB
- 0001477932-25-008410.txt ( ) — 160KB
- aspi-20251117.xsd (EX-101.SCH) — 5KB
- aspi-20251117_lab.xml (EX-101.LAB) — 15KB
- aspi-20251117_cal.xml (EX-101.CAL) — 1KB
- aspi-20251117_pre.xml (EX-101.PRE) — 10KB
- aspi-20251117_def.xml (EX-101.DEF) — 2KB
- aspi_8k_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On November 17, 2025, ASP Isotopes Inc. (the "Company") issued a press release announcing it will hold a quarterly business update conference call and webcast on Friday, November 21, 2025 at 8:30 a.m. (Eastern Time). A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated November 17, 2025. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: November 17, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3